Celanese CorporationCENYSE
Loading
R&D Expense Growth TrendStable
Percentile Rank67
3Y CAGR-59.3%
5Y CAGR-9.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-59.3%/yr
Quarterly compound
5Y CAGR
-9.3%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 3.23% |
| Q3 2025 | 0.00% |
| Q2 2025 | 0.00% |
| Q1 2025 | 0.00% |
| Q4 2024 | -3.13% |
| Q3 2024 | -3.03% |
| Q2 2024 | -2.94% |
| Q1 2024 | 6.25% |
| Q4 2023 | 0.00% |
| Q3 2023 | -20.00% |
| Q2 2023 | -4.76% |
| Q1 2023 | 13.51% |
| Q4 2022 | 48.00% |
| Q3 2022 | -3.85% |
| Q2 2022 | 8.33% |
| Q1 2022 | 4.35% |
| Q4 2021 | 9.52% |
| Q3 2021 | -4.55% |
| Q2 2021 | 10.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | 5.26% |
| Q3 2020 | 5.56% |
| Q2 2020 | 5.88% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 6.25% |
| Q1 2019 | -11.11% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | -5.26% |
| Q4 2017 | 0.00% |
| Q3 2017 | 11.76% |
| Q2 2017 | 0.00% |
| Q1 2017 | -15.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 5.26% |
| Q2 2016 | 0.00% |
| Q1 2016 | -9.52% |